Amneal Pharmaceuticals, Inc. Class A Common Stock
AMRX
AMRX: Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
moreShow AMRX Financials
Recent trades of AMRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AMRX's directors and management
Government lobbying spending instances
-
$40,000 Apr 20, 2022 Issue: Pharmacy
-
$60,000 Jan 20, 2022 Issue: Pharmacy
-
$60,000 Oct 20, 2021 Issue: Pharmacy
-
$60,000 Jul 20, 2021 Issue: Pharmacy
-
$60,000 Apr 20, 2021 Issue: Pharmacy
-
$60,000 Jan 21, 2021 Issue: Pharmacy
-
$60,000 Oct 20, 2020 Issue: Pharmacy
-
$50,000 Jul 20, 2020 Issue: Pharmacy
-
$20,000 Feb 01, 2019 Issue: None
-
$20,000 Jan 18, 2019 Issue: None
-
$20,000 Oct 08, 2018 Issue: None
-
$20,000 Jul 12, 2018 Issue: None
-
$40,000 Apr 16, 2018 Issue: Health Issues Budget/Appropriations
-
$40,000 Jan 20, 2018 Issue: Trade (domestic/foreign) Health Issues
-
$40,000 Dec 28, 2017 Issue: Health Issues
-
$40,000 Oct 19, 2017 Issue: Health Issues
-
$40,000 Jul 19, 2017 Issue: Health Issues
-
$40,000 Apr 20, 2017 Issue: Health Issues
-
$40,000 Oct 20, 2016 Issue: Pharmacy Health Issues
-
$40,000 Jul 19, 2016 Issue: Health Issues Pharmacy
-
$40,000 Apr 14, 2016 Issue: Pharmacy Health Issues
-
$40,000 Jan 15, 2016 Issue: Pharmacy Budget/Appropriations Copyright/Patent/Trademark Health Issues
-
$40,000 Oct 19, 2015 Issue: Pharmacy Health Issues Copyright/Patent/Trademark
-
$40,000 Jul 14, 2015 Issue: Pharmacy Health Issues Budget/Appropriations
-
$10,000 Apr 17, 2015 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
-
$40,000 Apr 17, 2015 Issue: Health Issues Budget/Appropriations Pharmacy
-
$30,000 Jan 20, 2015 Issue: Pharmacy
-
$20,000 Jan 18, 2015 Issue: Insurance Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Pharmacy
-
$10,000 Oct 18, 2014 Issue: Pharmacy Taxation/Internal Revenue Code Health Issues Budget/Appropriations Insurance Food Industry (safety, labeling, etc.) Medicare/Medicaid
-
$30,000 Oct 15, 2014 Issue: Pharmacy
-
$30,000 Jul 18, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
-
$30,000 Apr 16, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
-
$25,000 Jan 16, 2014 Issue: Budget/Appropriations Health Issues Pharmacy
New patents grants
Federal grants, loans, and purchases
- $2,200,000 2021-01-08 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $100,500 2019-01-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $81,618 2018-12-04 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $165,196 2018-11-06 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $193,032 2018-09-06 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $150,647 2018-07-05 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $175,526 2018-06-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $59,127 2018-05-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $70,176 2018-01-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Followers on AMRX's company Twitter account
Number of mentions of AMRX in WallStreetBets Daily Discussion
Recent insights relating to AMRX
Recent picks made for AMRX stock on CNBC
ETFs with the largest estimated holdings in AMRX
Flights by private jets registered to AMRX